Skip to main content

Featured

Eddie Bauer Launches Nationwide Liquidation Sales in Canada

                              An Eddie Bauer store in Vaughan, Ont., on Wednesday, Feb. 4, 2026.   Eddie Bauer has begun liquidation sales across its Canadian stores as the retailer undergoes a major restructuring effort. The move follows financial challenges that have pushed the company to streamline operations while exploring potential buyers. All Canadian locations are expected to remain open during the liquidation period, offering discounts as inventory is cleared. The retailer has indicated that if a suitable buyer emerges, it may shift from winding down operations to pursuing a sale that keeps some stores running. Eddie Bauer, long known for its outdoor apparel and gear, has faced mounting pressures from changing consumer habits and a competitive retail landscape. The coming weeks will determine whether the brand can secure a path forward or complete its exit from the Canadian market....
Post a Comment
Read more

article

Labels

Alzheimer’s vaccines get a boost from new drug approval

 

After decades of disappointment and controversy, the field of Alzheimer’s disease research has finally seen a breakthrough with the approval of the first drug that targets the underlying pathology of the condition. 

Aducanumab, a monoclonal antibody that clears amyloid plaques from the brain, was granted accelerated approval by the US Food and Drug Administration in June 2021, despite mixed results from clinical trials and objections from some experts. 

The drug’s approval has rekindled interest in other therapeutic approaches that aim to prevent or slow down the progression of Alzheimer’s, such as vaccines that stimulate the immune system to attack amyloid or tau, another protein that accumulates in the brains of people with the disease. 

Several vaccine candidates are currently in various stages of development and testing, and some researchers are optimistic that they could offer a more effective and convenient way to treat Alzheimer’s than infusions of antibodies.


Labels:

Comments

Post a Comment